# Rosuvastatin and Ischemia Reperfusion

> **NCT00315510** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 20 (—)

## Conditions studied

- Ischemia

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT00315510
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00315510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00315510, "Rosuvastatin and Ischemia Reperfusion". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00315510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*